Research map: Open‐Label, Balanced, Randomized, Single‐Dose, Three‐Treatment, Three‐Sequence, Three‐Period, Three‐Way Crossover Oral Bioequivalence Study of Desmopressin Acetate Oral Solution

Papers in this map

1. Diagnosis and Management of Central Diabetes Insipidus in Adults · Maria Tomkins · 2022 · 164 citations · Cited by this paper
2. Thorough QT Study on the Effect of Therapeutic and Supratherapeutic Dosing of Givinostat in Healthy Volunteers · 2026 · Related
3. Effect of food intake on the pharmacokinetics and antidiuretic activity of oral desmopressin (DDAVP) in hydrated normal subjects · Søren Rittig · 1998 · 62 citations · Cited by this paper
4. Distributed Manufacturing, Foreign Establishments, and Why the FDA's New Proposed Rule Matters to Clinical Pharmacology · 2026 · Related
5. Vasopressin and Its Analogues: From Natural Hormones to Multitasking Peptides · Mladena Glavaš · 2022 · 61 citations · Cited by this paper
6. Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Voriconazole Tablets in Healthy Chinese Volunteers · 2026 · Related
7. Management of central diabetes insipidus · Aoife Garrahy · 2020 · 60 citations · Cited by this paper
8. Pharmacokinetics and Bioequivalence of Tamsulosin Hydrochloride Extended‐Release Capsules in Healthy Chinese Volunteers: A Randomized, Open‐Label, Crossover Study Under Fasting and Fed Conditions · 2026 · Related
9. Diabetes insipidus · Mirjam Christ‐Crain · 2021 · 53 citations · Cited by this paper
10. Pharmacokinetic Interaction Between Atorvastatin and Hybutimibe in Healthy Chinese Volunteers · 2026 · Related
11. Approach to the Pediatric Patient: Central Diabetes Insipidus · Giuseppa Patti · 2022 · 37 citations · Cited by this paper
12. Single‐Dose Pharmacokinetic Assessment of TNX‐102 SL (Cyclobenzaprine HCl Sublingual Tablets): Results From Randomized, Open‐Label Studies in Healthy Volunteers · 2026 · Related
13. α-Chymotrypsin-catalyzed degradation of desmopressin (dDAVP): influence of pH, concentration and various cyclodextrins · Karin Fredholt · 1999 · 28 citations · Cited by this paper
14. From Reflection to Acceleration: Clinical Pharmacology’s 2025 Lessons and 2026 Opportunities · 2026 · Related
15. Desmopressin duration of antidiuretic action in patients with central diabetes insipidus · Kristian Vinter Juul · 2011 · 27 citations · Cited by this paper
16. Pharmacokinetic Comparability of ABP 654, a Biosimilar to Ustekinumab, Administered Either via Prefilled Syringe or Autoinjector in Healthy Adults: Results from a Randomized, Open‐Label, Parallel‐Group Study · 2026 · Related
17. Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus · The Working Group for Renaming Diabetes Insipidus · 2022 · 25 citations · Cited by this paper
18. Pharmacokinetics and Safety of VV116 in Subjects With Mild or Moderate Hepatic Impairment Compared With Healthy Controls: A Phase I, Open‐Label Study · 2026 · Related
19. Central and nephrogenic diabetes insipidus: updates on diagnosis and management · Kathryn E. Flynn · 2025 · 24 citations · Cited by this paper
20. A Phase 1 Bioequivalence Study to Assess the Pharmacokinetics, Safety and Tolerability of Guselkumab After a Single‐Dose Administration via Two Subcutaneous Injection Devices in Healthy Volunteers · 2026 · Related
21. A PHARMACOKINETIC AND PHARMACODYNAMIC COMPARISON OF DESMOPRESSIN ADMINISTERED AS WHOLE, CHEWED AND CRUSHED tablets, AND AS AN ORAL SOLUTION · Domenick Argenti · 2001 · 16 citations · Cited by this paper
22. Desmopressin therapy in children and adults: pharmacological considerations and clinical implications · Xinyi Chin · 2022 · 15 citations · Cited by this paper
23. A Bioequivalence Study of Two Oral Desmopressin Tablet Formulations · Stefan T. Kaehler · 2006 · 7 citations · Cited by this paper
24. Desmopressin dosing in children using real-world data and pharmacokinetic/pharmacodynamic model simulations · Kevin Yen · 2024 · 3 citations · Cited by this paper

Source: OpenAlex (CC0)